Eligibility of the Systolic Blood Pressure Intervention Trial (SPRINT) to the Chinese Adults
المؤلفون المشاركون
Chen, Liping
Zhang, Yiyan
Jin, Juan
Li, Nannan
Liu, Dan
Zhai, Xinkun
Chen, Xiaodong
Yuan, Xiaodan
المصدر
العدد
المجلد 2020، العدد 2020 (31 ديسمبر/كانون الأول 2020)، ص ص. 1-7، 7ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2020-10-19
دولة النشر
مصر
عدد الصفحات
7
التخصصات الرئيسية
الملخص EN
Objective.
To explore the proportion and characteristic of Chinese adults meeting The Systolic Blood Pressure Intervention Trial (SPRINT) eligibility criteria and assess its generalizability.
Method.
Our study was based on a cross-sectional, population-based survey with a sample of 26,093 participants aged over 20 years.
The SPRINT eligibility criteria were age≥50 years, elevated SBP of 130 to 180 mmHg depending on the number of antihypertensive medication classes being taken, and increased cardiovascular disease (CVD) but without diabetes, history of stroke and estimated glomerular filtration rate<20 ml/min/1.73 m2, or receiving dialysis.
Results.
Overall, we estimated that 4,036 (15.5%) participants would meet the SPRINT eligibility criteria.
They were generally older, likely to be female, lower educational level, tended to be more overweight, and had higher Framingham risk score compared with overall population or subjects aged≥50 years.
Of participants eligible for SPRINT, most (56.2%) of them were not treated for hypertension, and 542 (13.4%) were not previously considered to have hypertension or need for antihypertension therapy.
Among the 11,637 adults with hypertension, 3,494 (30.0%) would potentially benefit from treatment intensification.
The most common antihypertensive medication class being taken was diuretic agents.
Conclusion.
A substantial percentage of Chinese subjects meet the SPRINT eligibility criteria.
Further studies are needed to assess the cost-effectiveness from treatment intensification in Chinese setting.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Chen, Liping& Zhang, Yiyan& Jin, Juan& Li, Nannan& Liu, Dan& Zhai, Xinkun…[et al.]. 2020. Eligibility of the Systolic Blood Pressure Intervention Trial (SPRINT) to the Chinese Adults. BioMed Research International،Vol. 2020, no. 2020, pp.1-7.
https://search.emarefa.net/detail/BIM-1134178
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Chen, Liping…[et al.]. Eligibility of the Systolic Blood Pressure Intervention Trial (SPRINT) to the Chinese Adults. BioMed Research International No. 2020 (2020), pp.1-7.
https://search.emarefa.net/detail/BIM-1134178
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Chen, Liping& Zhang, Yiyan& Jin, Juan& Li, Nannan& Liu, Dan& Zhai, Xinkun…[et al.]. Eligibility of the Systolic Blood Pressure Intervention Trial (SPRINT) to the Chinese Adults. BioMed Research International. 2020. Vol. 2020, no. 2020, pp.1-7.
https://search.emarefa.net/detail/BIM-1134178
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1134178
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر